Bruker Corporation (NASDAQ:BRKR) : 5 brokerage houses believe that Bruker Corporation (NASDAQ:BRKR) is a Strong Buy at current levels. 6 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Bruker Corporation (NASDAQ:BRKR). Zacks Investment Research suggests a Hold with a rank of 3. 1 analysts perceive the stock to be overvalued at the existing levels, hence their call is to Sell the stock.The median of all the 12 Wall Street Analysts endorse the stock as a Buy with a rating of 2.25.
Bruker Corporation (NASDAQ:BRKR) : The highest level Bruker Corporation (NASDAQ:BRKR) is projected to reach is $34 for the short term and the lowest estimate is at $25. The consolidated price target from 10 rating analysts who initiate coverage on the stock is $29 and the possibility the share price can swing is $2.91.
Company shares have received an average consensus rating of Hold for the current week Also, In the latest statement by the brokerage house, BTIG Research downgrades its outlook on Bruker Corporation (NASDAQ:BRKR). The current rating of the shares is Neutral, according to the research report released by the firm. Previously, the company had a rating of Buy. The rating by the firm was issued on May 5, 2016.
Bruker Corporation (NASDAQ:BRKR): stock turned positive on Tuesday. Though the stock opened at $22.09, the bulls momentum made the stock top out at $22.44 level for the day. The stock recorded a low of $21.84 and closed the trading day at $22.08, in the green by 0.55%. The total traded volume for the day was 1,358,371. The stock had closed at $21.96 in the previous days trading.
In an insider trading activity, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the CEO of Bruker Corp, Laukien Frank H, had purchased 4,174 shares in a transaction dated on June 14, 2016. The transaction was executed at $23.95 per share with total amount equaling $99,967.
Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.